Lead, Whole Blood (Maternal)
Use
Monitor maternal blood for environmental lead exposure. The Centers for Disease Control and Prevention recommends the following testing schedule for frequency of maternal blood lead follow-up during pregnancy.1 See table.
Special Instructions
Not provided.
Limitations
This test was developed and its performance characteristics determined by LabCorp. It has not been cleared or approved by the Food and Drug Administration (FDA). As such, it should not be considered diagnostic but rather a tool to assist in monitoring lead exposure. Its limitations include the potential for sample contamination and variations in detection sensitivity and specificity. Consultation with a clinician experienced in the management of pregnant women with elevated blood lead levels is advised for results interpretation.
Methodology
Mass Spectrometry
Biomarkers
Lead
Analyte
LOINC Codes
- 77307-7 - Lead BldV-mCnc
- 77307-7 - Lead BldV-mCnc
Result Turnaround Time
2-4 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
3 mL
Minimum Volume
0.5 mL
Container
Royal blue-top (EDTA) tube or tan-top lead-free tube
Collection Instructions
Mix blood thoroughly to avoid clotting.
Storage Instructions
Maintain specimen at room temperature.
Causes for Rejection
Clotted specimen
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 14 days |
| Refrigerated | 14 days |
| Frozen | 14 days |
Other tests from different labs that may be relevant